MITOCHONDRIA-TARGETED ANTIOXIDANTS FOR TREATMENT OF PARKINSON’S DISEASE: PRECLINICAL AND CLINICAL OUTCOMES

Parkinson’s disease (PD) is a progressive neurodegenerative disease in the elderly, and no cure or disease-modifying therapies exist. Several lines of evidence suggest that mitochondrial dysfunction and oxidative stress have a central role in the dopaminergic neurodegeneration of PD. In this context...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jin, Huajun, Kanthasamy, Arthi, Ghosh, Anamitra, Anantharam, Vellareddy, Kalyanaraman, Balaraman, Kanthasamy, Anumantha G.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3961561/
https://ncbi.nlm.nih.gov/pubmed/24060637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbadis.2013.09.007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares